Antibiotic-Induced Liver Toxicity: Mechanisms, Clinical Features and Causality Assessment
The DOI matches its Crossref record.
Abstract
Antibiotics are the therapeutic agents most often associated with hepatotoxicity. However, this is mainly due to the widespread prescription of these drugs. The relative risk of antibiotic-related hepatotoxicity is low. Causality assessment of suspected drug-induced liver injury (DILI) related to antibiotics can be difficult, particularly because some cases occur long after the drug has been stopped. Among the penicillins, amoxicillin clavulanate is the most associated with hepatotoxicity and is the most frequent cause of DILI-related hospitalisations. Flucloxacillin ranks as the second highest cause of DILI in many countries. The severity of antibiotic-induced DILI varies widely, with the hepatitis-like (hepatocellular) damage tending to be more severe that than cholestatic/mixed type. The pattern is strongly influenced by age. Recently telithromycin (a new generation macrolide) has been linked with DILI, with a typical pattern, which includes abrupt commencement of fever, abdominal pain, jaundice and, in some cases, ascites. Antibiotic-induced DILI appears, in most instances, to be idiosyncratic. Genetic-association studies have recently identified genotypes related to flucloxacillin and possibly to amoxicillin-clavulanate hepatotoxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Still being checked.
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Dawson, S., Stahl, S., Paul, N., Barber, J., & Kenna, J. G. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040758 · Cited by 343
Cameron, D. J., Johnson, L. B., & Maloney, E. L. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.940900 · Cited by 190
Clinical and Histologic Features of Azithromycin-Induced Liver Injury
Martinez, M. A., Vuppalanchi, R., Fontana, R. J., Stolz, A., Kleiner, D. E., Hayashi, P. H., Gu, J., Hoofnagle, J. H., & Chalasani, N. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.054 · Cited by 132
Kern, W. V., Marchetti, O., Drgoňa, Ľ., Akan, H., Aoun, M., Akova, M., Bock, R. D., Paesmans, M., Viscoli, C., & Calandra, T. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8109 · Cited by 96
Woodhead, J. L., Yang, K., Oldach, D., MacLauchlin, C., FERNANDES, P. B., Watkins, P. B., Siler, S. Q., & Howell, B. A. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2582-y · Cited by 73
Drug-induced liver injury: a summary of recent advances
Stine, J. G., & Lewis, J. H. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.577415 · Cited by 53
Albendazole-induced granulomatous hepatitis: a case report
Marin Zuluaga, J. I., Marin Castro, A. E., Perez Cadavid, J. C., & Restrepo Gutierrez, J. C. (2013) · Journal of Medical Case Reports · doi:10.1186/1752-1947-7-201 · Cited by 45
Mahmud, K. M., Hossain, M. M., Polash, S. A., Takikawa, M., Shakil, M. S., Uddin, M. F., Alam, M., Shawan, M. M. A. K., Saha, T., Takeoka, S., et al. (2022) · ACS Omega · doi:10.1021/acsomega.2c01922 · Cited by 45
Ferrajolo, C., Verhamme, K. M. C., Trifirò, G., ‘t Jong, G. W., Picelli, G., Giaquinto, C., Mazzaglia, G., Stricker, B. H., Rossi, F., Capuano, A., et al. (2017) · Drug Safety · doi:10.1007/s40264-016-0493-y · Cited by 33
Bactericidal activities of GM flax seedcake extract on pathogenic bacteria clinical strains
Żuk, M., Dorotkiewicz‐Jach, A., Drulis‐Kawa, Z., Arendt, M., Kulma, A., & Szopa, J. (2014) · BMC Biotechnology · doi:10.1186/1472-6750-14-70 · Cited by 34
Hossain, M. M., Hamza, A., Polash, S. A., Tushar, M. H., Takikawa, M., Piash, A. B., Dekiwadia, C. D., Saha, T., Takeoka, S., & Sarker, S. R. (2024) · RSC Pharmaceutics · doi:10.1039/d3pm00077j · Cited by 32
Exploration of Biomarkers for Amoxicillin/Clavulanate‐Induced Liver Injury: Multi‐Omics Approaches
Lee, J., Ji, S., Kim, B., Yi, S., Shin, K., Cho, J. Y., Lim, K., Lee, S. H., Yoon, S., Chung, J., et al. (2016) · Clinical and Translational Science · doi:10.1111/cts.12425 · Cited by 32
Antibiotic-induced Elevations of Plasma Bile Acids in Rats Independent of Bsep Inhibition
Li, Y., Hafey, M. J., Duong, H., Evers, R., Cheon, K., Holder, D., Galijatovic-Idrizbegovic, A., Sistare, F. D., & Glaab, W. E. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx015 · Cited by 26
Amoxicillin‐Clavulanic Acid Hepatotoxicity in Children
Hita, E. O., García, J. A. M., González, J. C., Molina, A. A., Cordero, M. J. A., Escobar, J. S., & Ruiz‐Extremera, A. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318263ebfa · Cited by 22
Metabolomics of Hydrazine-Induced Hepatotoxicity in Rats for Discovering Potential Biomarkers
An, Z., Li, C., Lv, Y., Li, P., Wu, C., & Liu, L. (2018) · Disease Markers · doi:10.1155/2018/8473161 · Cited by 21
A Developmental Approach to Drug-induced Liver Injury in Newborns and Children
Faa, G., Ekström, J., Castagnola, M., Gibo, Y., Ottonello, G., & Fanos, V. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803306385 · Cited by 21
Rutkoski, C. F., Grott, S. C., Israel, N. G., Carneiro, F. E., Guerreiro, F. D. C., dos Santos, S. C. S., Horn, P. A., Trentini, A. A., da Silva, E. B., de Albuquerque, C. A. C., et al. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136215 · Cited by 17
Hepatotoxicidad por fármacos o productos naturales en niños
Ocete Hita, E., Martín García, J. A., Giménez Sánchez, F., Flores González, J. C., Abril Molina, A., Salmerón Escobar, J., & Ruiz Extremera, A. (2013) · Anales de Pediatría · doi:10.1016/j.anpedi.2012.06.012 · Cited by 10
Cha, S., Lee, J., Kim, E.-A., Shin, C. H., Jun, H., & Jeon, Y. (2017) · RSC Advances · doi:10.1039/c7ra05994a · Cited by 16
Mosedale, M., Wu, H., Kurtz, C. L., Schmidt, S. P., Adkins, K., & Harrill, A. H. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.06.013 · Cited by 15
Stavrakeva, K., Popova, M., Esad, M., Apostolova, E., Kokova, V., Bacelova, M., Alakidi, A., & Bivolarska, A. V. (2024) · Acta Medica Bulgarica · doi:10.2478/amb-2024-0083 · Cited by 13
Acute Liver Failure Induced by Anti-infectious Drugs: Causes and Management
Devarbhavi, H. C. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0367-5 · Cited by 11
Yu, Z., Wu, F., Tian, J., Guo, X., An, R., & Guo, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.18291 · Cited by 10
Akhtara, N., & Bharali, M. K. (2025) · Molecular & Cellular Toxicology · doi:10.1007/s13273-025-00524-3 · Cited by 9
Genetic Variations and Antibiotic-Related Adverse Events
Principi, N., Petropulacos, K., & Esposito, S. (2024) · Pharmaceuticals · doi:10.3390/ph17030331 · Cited by 8
A selenium-enriched diet helps to recover liver function after antibiotic administration in mice
Huertas-Abril, P. V., Prieto‐Álamo, M., Jurado, J., García‐Barrera, T., & Abril, N. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113519 · Cited by 7
Munz, M., Grummich, H., Birkmann, J., Wilhelm, M., Holzgrabe, U., & Sörgel, F. (2017) · Chemotherapy · doi:10.1159/000480399 · Cited by 7
Sanni, S., Sina, H., & Baba‐Moussa, L. (2022) · Journal of Tuberculosis Research · doi:10.4236/jtr.2022.103010 · Cited by 6
Safety in the selection of oral antibiotic treatment in community infections, beyond COVID-19
Barberán, J., Barberán, L. C., & de la Cuerda, A. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/087.2021 · Cited by 5
Infections in Alcoholic Liver Disease
Kim, A. C., Epstein, M. E., Gautam‐Goyal, P., & Doan, T.-L. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.08.008 · Cited by 5
Toxicity consideration of antibiotics
Ali, S. S., Ali, A. M. M., Elsamahy, T., Okasha, K. M., & Sun, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95388-7.00008-5 · Cited by 4
Metabolomics in drug discovery: Restoring antibiotic pipeline
Azhar, F., Busharat, M., Chaudhary, S. R. A., Waheed, Z., & Jamil, M. N. (2023) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.385568 · Cited by 4
Hepatitis colestásica aguda asociada a levofloxacino
Titos-Arcos, J. C., Hallal, H., Robles‐Díaz, M., & Andrade, R. J. (2011) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2011.01.011 · Cited by 4
Hu, J., Xu, H., Sun, P., Huang, Y.-Q., Liu, X., & Fan, Q. (2026) · The Analyst · doi:10.1039/d5an01366f · Cited by 3
Chai, J., Wu, J., Yang, J., Ye, T., Gao, Y., Zeng, B., Xiong, W., Kotsyfakis, M., Dijkgraaf, I., Liu, J., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113332 · Cited by 3
Bruckner, D. M., Connerney, J., & Dordick, J. S. (2018) · AIChE Journal · doi:10.1002/aic.16442 · Cited by 3
A biomimetic nano-NET strategy for the treatment of MRSA-related implant-associated infection
Xu, H., He, D., & Tao, H. (2025) · RSC Advances · doi:10.1039/d5ra00367a · Cited by 3
Ninan, N., Wei, F., Palms, D., Zilm, P. S., Zhao, Y., Bright, R., Xiao, Y., & Vasilev, K. A. (2025) · Regenerative medicine and dentistry. · doi:10.53941/rmd.2025.100011 · Cited by 2
Akhtara, N., Bharali, M. K., Chakraborty, M., & Thakur, S. P. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70115 · Cited by 2
Minuk, G. Y., Nicolle, L. E., Yogendran, M. S., & Uhanova, J. (2025) · Canadian Liver Journal · doi:10.3138/canlivj-2024-0052 · Cited by 2
Drug Safety in Children: Focus on hepatic concerns
Ferrajolo, C. (2014) · RePub (Erasmus University Rotterdam) · Cited by 2
The current state of the problem of drug hepatotoxicity and measures of its prevention and treatment
Shmanko, V. V., Shmanko, O. V., & Лазарчук, Т. Б. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.30.01.010 · Cited by 1
Bermúdez-Pérez, I. V., Álvarez‐Álvarez, I., Medina‐Cáliz, I., Robles‐Díaz, M., Niu, H., Chen, M., Andrade, R. J., Lucena, M. I., Stephens, C. M., & Gonzalez-Jimenez, A. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2525470 · Cited by 1
Drug Induced Hepatotoxicity – An Ongoing Challenge
Fatima, M., & Zaidi, S. (2020) · Journal of Bahria University Medical and Dental College · doi:10.51985/jbumdc2020007 · Cited by 1
Das, J. A., Azad, S., Kapp, M., Liu, W., & Nguyen, V. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-01814-6 · Cited by 1
Ahmed, K., Malahleha, M., JenniferDeese, Monedi, C., & Damme, L. V. (2013) · Journal of AIDS and HIV Research · doi:10.5897/jahr12.086
Ivanyshko–Nasarko, N. V. (2015) · ScienceRise · doi:10.15587/2313-8416.2015.57330
SALMERÓN-FERNÁNDEZ, M. J. (2016) · Institutional Repository of the University of Granada (University of Granada)
Profile of drug-induced liver injury due to antibiotics in patients with chronic liver disease
Rajesh, G., & Neethu, C. M. (2020) · Amrita Journal of Medicine · doi:10.4103/amjm.amjm_8_20
Kumar, S., & Qadir, A. (2024) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20243024
Principles of Antibiotic Adjustment in Renal Failure
Dias, B. F., & Santos, J. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Ishaq, B. H., Khan, Z. S., Junaid, N., Rehman, U. U., Khalid, K. U. R., & Shahzad, H. (2026) · Pakistan Journal of Clinical Research · doi:10.65761/pjcr.2026.314
Metadata
- Authors
- Robles, M., Toscano, E., Cotta, J., Isabel Lucena, M., & J. Andrade, R.
- Venue
- Current Drug Safety
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-07-01
- Volume
- 5
- Issue
- 3
- Pages
- 212-222
- ISSN
- 1574-8863 (ISSN-L)
- OpenAlex
- W2113986492
- Cited by
- 45
- References
- 0
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 2 · 2015: 1 · 2014: 5 · 2013: 4 · 2012: 3
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- drug-induced liver injury, amoxicillin-clavulanic acid, flucloxacillin, penicillin, telithromycin, macrolides, causality assessment, idiosyncratic drug reactions, genetic susceptibility, hepatocyte injury, cholestatic liver injury, age-related risk, adverse drug reactions
- MeSH terms
- Animals, Anti-Bacterial Agents, Genotype, Humans, Risk Factors, Severity of Illness Index, Time Factors, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.